World's Best Scientists 2026 revealed!
Irina Alafuzoff

Irina Alafuzoff

D-Index & Metrics

Medicine

D-Index
92
Citations
36611
World Ranking
11178
National Ranking
209

Irina Alafuzoff publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Irina Alafuzoff sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 343 publications — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Irina Alafuzoff D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Irina Alafuzoff sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 92 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Irina Alafuzoff is affiliated with Uppsala University in Sweden and contributes extensively to the field of medicine, with a particular focus on neurology, physiology, and molecular biology. Their research spans multiple topics related to neurodegenerative diseases and cognitive impairments.

Alafuzoff has published research on a variety of topics, including:

  • Alzheimer's disease research and treatments
  • Parkinson's Disease mechanisms and treatments
  • Dementia and cognitive impairment research
  • Neurological disorders and treatments
  • Ginkgo biloba and cashew applications
  • Amyloidosis: diagnosis, treatment, outcomes
  • Amyotrophic lateral sclerosis research

Their work has appeared in several academic venues, such as:

  • Journal of Alzheimer s Disease
  • Acta Neuropathologica
  • Proceedings of the National Academy of Sciences
  • International Journal of Molecular Sciences
  • Movement Disorders

Notable recent publications include:

  • "Ageing-Related Neurodegeneration and Cognitive Decline," 2024, International Journal of Molecular Sciences
  • "Biomarker-Based Approach to α-Synucleinopathies: Lessons from Neuropathology," 2024, Movement Disorders
  • "LATE-NC staging in routine neuropathologic diagnosis: an update," 2022, Acta Neuropathologica
  • "Modeling SHH-driven medulloblastoma with patient iPS cell-derived neural stem cells," 2020, Proceedings of the National Academy of Sciences
  • "Mixed Brain Pathology Is the Most Common Cause of Cognitive Impairment in the Elderly," 2020, Journal of Alzheimer s Disease

Alafuzoff has collaborated frequently with several researchers in their field, including:

  • Sylwia Libard
  • Peter T. Nelson
  • Edward B. Lee
  • Johannes Attems
  • Brittany N. Dugger

Their research largely concentrates on the pathological and clinical aspects of neurodegenerative diseases, contributing to both foundational knowledge and potential diagnostic approaches. The focus on biomarkers and neuropathological staging reflects an emphasis on improving disease understanding and clinical diagnosis.

The scientist's interdisciplinary work crosses neurology, physiology, molecular biology, psychiatry, and complementary medicine, demonstrating a broad approach to complex neurological disorders.

Best Publications

  • Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.

    Heiko Braak;Irina Alafuzoff;Thomas Arzberger;Hans Kretzschmar

  • Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature

    Peter T Nelson;Irina Alafuzoff;Eileen H Bigio;Constantin Bouras

  • Primary age-related tauopathy (PART): a common pathology associated with human aging

    John F. Crary;John Q. Trojanowski;Julie A. Schneider;Jose F. Abisambra

  • Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report.

    Peter T. Nelson;Dennis W. Dickson;John Q. Trojanowski;Clifford R. Jack

  • Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update

    Ian R. A. Mackenzie;Manuela Neumann;Eileen H. Bigio;Nigel J. Cairns

  • Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain

    Tero Tapiola;Irina Alafuzoff;Sanna-Kaisa Herukka;Laura Parkkinen

  • CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease

    Katharina Buerger;Michael Ewers;Tuula Pirttila;Raymond Zinkowski

  • Defective brain microtubule assembly in Alzheimer's disease.

    Khalid Iqbal;I. Grundke-Iqbal;T. Zaidi;P. A. Merz

  • Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions

    Vivianna M. Van Deerlin;Patrick M A Sleiman;Maria Martinez-Lage;Maria Martinez-Lage;Alice Chen-Plotkin

  • Staging of Neurofibrillary Pathology in Alzheimer's Disease: A Study of the BrainNet Europe Consortium

    Irina Alafuzoff;Thomas Arzberger;Safa Al-Sarraj;Istvan Bodi

  • Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy

    Gabor G. Kovacs;Isidro Ferrer;Lea T. Grinberg;Lea T. Grinberg;Irina Alafuzoff

  • Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathies.

    Erkki Kuusisto;Antero Salminen;Irina Alafuzoff

  • Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration : consensus recommendations

    Ian R. A. Mackenzie;Manuela Neumann;Eileen H. Bigio;Nigel J. Cairns

  • Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease.

    Wen-Lin An;Richard F. Cowburn;Lin Li;Heiko Braak

  • Levels of mTOR and its downstream targets 4E-BP1, eEF2, and eEF2 kinase in relationships with tau in Alzheimer's disease brain.

    Xu Li;Irina Alafuzoff;Hilkka Soininen;Bengt Winblad

  • Transmitter deficits in Alzheimer's disease.

    John Hardy;Rolf Adolfsson;Irina Alafuzoff;Gösta Bucht

  • Applicability of current staging/categorization of α-synuclein pathology and their clinical relevance

    Laura Parkkinen;Tuula Pirttilä;Irina Alafuzoff

  • Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia.

    A. Nordberg;I. Alafuzoff;B. Winblad

  • Staging/typing of Lewy body related α-synuclein pathology: a study of the BrainNet Europe Consortium

    Irina Alafuzoff;Paul G. Ince;Thomas Arzberger;Safa Al-Sarraj

  • Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis.

    I Alafuzoff;K Iqbal;H Friden;Rolf Adolfsson

Frequent Co-Authors

Hilkka Soininen
Hilkka Soininen University of Eastern Finland
Mikko Hiltunen
Mikko Hiltunen University of Eastern Finland
Gabor G. Kovacs
Gabor G. Kovacs University of Toronto
Tuula Pirttilä
Tuula Pirttilä University of Eastern Finland
Isidro Ferrer
Isidro Ferrer University of Barcelona
Bengt Winblad
Bengt Winblad Karolinska Institute
Hans A. Kretzschmar
Hans A. Kretzschmar Ludwig-Maximilians-Universität München
Herbert Budka
Herbert Budka Medical University of Vienna
Paul G. Ince
Paul G. Ince University of Sheffield
Piero Parchi
Piero Parchi University of Bologna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a medical career path but aren't ready for the full rigors of medical school, there are several accessible online options worth exploring. Many roles in healthcare do not require an MD but still offer stability, good salaries, and a chance to make a real difference.

For those interested in healthcare administration or medical office settings, pursuing programs from medical billing and coding schools that accept financial aid can be a practical first step. These programs are typically flexible, affordable, and in high demand across the healthcare sector.

If nursing appeals to you but you're concerned about admission exams, there are nursing schools that don't require teas test. These institutions may offer a smoother and more accessible pathway to becoming a registered nurse.

For those aiming for administrative leadership, explore a healthcare administration online degree. These accelerated programs are ideal for professionals looking to advance rapidly and manage healthcare services.

Lastly, if you’re a nurse seeking career advancement, consider adn to fnp programs. These bridge programs allow you to move from an associate degree in nursing to becoming a family nurse practitioner, expanding your scope and potential earnings.

Best Scientists Citing Irina Alafuzoff

Trending Scientists

Recently Published Articles